Safety of Arthritis Drugs, Day 3, Part 3

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis… read more

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Trontell gave a presentation on the FDA’s regulatory options used for problem drugs. Options included labeling details, limitations on drug amounts, restriction of prescriptions, and market withdrawal. The committee members questioned her and continued assessing the safety records of arthritis drugs. 

The function of the advisory committees, chaired by Dr. Wood, is to provide advice and recommendations to the FDA on regulatory issues. close

*The transcript for this program was compiled from uncorrected Closed Captioning.

People in this video

  • Abramson, Steven Chairman New York University Medical School->Rheumatology
  • Bathon, Joan Professor Johns Hopkins University->Medical School
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 3,

More Videos
More information about

Safety of Arthritis Drugs, Day 3, Part 3

109 Views
Program ID:
185600-3
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 25, 2005

Airing Details

  • Feb 25, 2005 | 11:55am EST | C-SPAN 2
Purchase a DVD or Download

Safety of Arthritis Drugs, Day 3, Part 3

  • DVD
    Length:
    01:56:13
    Price:
    $29.95
    Add to Cart
  • MP3 audio
    Length:
    01:56:13
    Price:
    $0.99
    Add to Cart

Clips from This Video